Skip to main content

ScienceDex / Researcher record

Christopher J. Lindsell

FY2026 NIH rank #154
  • Top 1% Funded
  • Program Leader
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2026

$21.5M
Full award amounts, FY2026
4
Records listing this PI
#154
By linked amount among FY2026 PIs
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2024$12,084,8753#249
2025$21,555,7983#88
2026$21,505,9104#154

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20243 records
  2. FY20253 records
  3. FY2026 · selected4 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Christopher J. Lindsell. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCATS

National Center for Advancing Translational Sciences

$14.7M

2 awards · administering

NHLBI

National Heart, Lung, and Blood Institute

$4.6M

2 awards · administering

NIGMS

National Institute of General Medical Sciences

$2.2M

2 awards · funding

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 7052782Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2026 award categories

  • Internal Medicine

FY2026 award records by amount

NIH award records listing Christopher J. Lindsell as a PI. Multi-PI records show the full award amount for context.

  • 5UM1TR005436-02UM1Co-investigator
    CTSA UM1 at Duke University
    Duke University · Internal Medicine (NIH department code)
    $9.9M
    award amount
  • 5U01HL168478-04U01Co-investigator
    Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE)
    $6.7M
    award amount
  • 5U24TR004437-04U24Co-investigator
    Engaging Cooperative Sites for Trial Acceleration, Trust, Innovation, and Capability (ECSTATIC)
    $4.8M
    award amount
  • 3U01HL168478-04S1U01Co-investigator
    Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE)
    $109.1K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Christopher J. Lindsell as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Vanderbilt University Medical Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #249
  8. 2024
    Entered Top 25% Nationally
    Ranked #249
  9. 2024
    Entered Top 10% Nationally
    Ranked #249
  10. 2024
    Entered Top 5% Nationally
    Ranked #249
  11. 2025
    $25M Cumulative Funding
  12. 2025
    Entered Top 1% Nationally
    Ranked #88
  13. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  14. 2025
    Program/Center Grant Leader
  15. 2026
    $50M Cumulative Funding